{"id":41159,"date":"2014-01-22T10:55:06","date_gmt":"2014-01-22T15:55:06","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=voices&p=41159"},"modified":"2014-01-27T15:32:42","modified_gmt":"2014-01-27T20:32:42","slug":"series-making-sense-of-the-new-prevention-guidelines-the-view-from-clinical-practice","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2014\/01\/22\/series-making-sense-of-the-new-prevention-guidelines-the-view-from-clinical-practice\/","title":{"rendered":"SERIES: Making Sense of the New Prevention Guidelines \u2014 The View from Clinical Practice"},"content":{"rendered":"

Several new guidelines for prevention of cardiovascular events and related controversies have created substantial turmoil and uncertainty in clinical practice. In the past three months, we have had four new sets of ACCF\/AHA Clinical Practice Guidelines, including a novel approach to lipid management; a statement on blood pressure (BP) management from the AHA; new BP guidelines, published in JAMA<\/i>, from the JNC-8 authors; a dissenting editorial from five of those authors in the Annals of Internal Medicine<\/i>; and a promise from AHA\/ACCF to issue new BP guidelines by the end of 2014 or early 2015.<\/p>\n

CardioExchange would like to provide a platform for rich discussion of particular clinical situations for which the new guidelines are pertinent. We will present some brief vignettes of patient encounters and ask you, the members of CardioExchange, to submit your own vignettes<\/a> to be considered as brief blog posts for this series (100 to 300 words in length). Your grassroots experience is invaluable.<\/p>\n

Important sources related to this topic are provided for your reference below. Thank you in advance for your participation.<\/p>\n

Sources<\/span><\/b><\/p>\n